Navigation Links
Alexza to Announce 2010 First Quarter Financial Results on Monday, May 10, 2010
Date:4/29/2010

atories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada.    

Alexza has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and has completed two Phase 2 studies with AZ-104 (Staccato loxapine, low-dose). Both product candidates are being developed for the acute treatment of migraine headache.  

AZ-002 (Staccato alprazolam) has completed Phase 1 testing and one Phase 2a proof-of-concept clinical trial.  Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, and AZ-007 (Staccato zaleplon) for the treatment of insomnia.  More information, including this and past press releases from Alexza, is available online at www.alexza.com.

Safe Harbor Statement

The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs.  The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statem
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
2. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
3. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
4. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
5. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
6. Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
7. Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
8. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
9. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
(Date:7/2/2015)... DIEGO , July 2, 2015 ResMed Inc. ... its fourth quarter and fiscal year ended June 30, 2015 ... Stock Exchange market close. A press release with ResMed,s results ... the company will host a webcast to discuss operating results ... to begin at 1:30 p.m. US Pacific Time and the ...
(Date:7/2/2015)... 2, 2015 Releases of the ... Aedes aegypti , , reduced the dengue mosquito ... by 95%, well below the modelled threshold ... , The journal PLOS Neglected Tropical Diseases ... genetically engineered mosquitoes. The results showed that in Juazeiro ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
(Date:7/2/2015)... ... 02, 2015 , ... Six months ahead of his 80th birthday, Don Stevenson ... and money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk in ... D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making his way ...
(Date:7/2/2015)... ... July 02, 2015 , ... When The American Journal ... late June Web-based session, the speakers discussed the importance of accountable care organizations ... through coordinated care. , During the session, participants learned the ins and outs ...
(Date:7/2/2015)... , ... July 02, 2015 ... ... janitorial supply company , announced today that it has reached an ... acquisition will make CleanItSupply.com the largest distributor of Rubbermaid Commercial Products on ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... and wrist pain treatment. Dr. Lev Kalika, founder of New York Dynamic ... international authority on the conservative treatment of back, hip, knee and shoulder pain ...
(Date:7/2/2015)... ... 2015 , ... Five individuals from Loma Linda University Health ... disaster training. The team – composed of four clinicians and one administrative staff ... attended the training, which is dedicated to preparing first responders for a mass ...
Breaking Medicine News(10 mins):Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3
... growing brain tumors must adjust to periods of low ... cells grow and proliferate. When levels are low, the ... Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer ... the switch responsible for this grow-or-go behavior. , Their ...
... that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala . , ... , , ... ... ...
... author, and lecturer Dr. William Sears and his product team have announced the launch of ... Expo West convention to be held in Anaheim, CA March 12-14 . The company,s ... ... ...
... ... and food security has wide-ranging benefits compared to its costs in the fight against ... Congressional hearing on global hunger. He cites findings from Nobel laureates and a Lancet ... ...
... ... ... 11, 2010 -- Qualifacts Systems Inc. , the largest Software as a Service ... and human services providers, has added New Directions Inc. to its client roster – ...
... ... President of International Orion Health – Charles Scatchard. Orion Health celebrates “phenomenal success” with ... , ... (PRWEB) March 12, 2010 -- To further the ongoing success with implementing Healthcare IT ...
Cached Medicine News:Health News:Researchers discover brain tumor's 'grow-or-go' switch 2Health News:Researchers discover brain tumor's 'grow-or-go' switch 3Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 2Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 3Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 4Health News:Hard to Treat Diseases (HTDS) Acquired Varicella Approval in Guatemala 5Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 2Health News:America's Pediatrician Dr. Bill Sears Answers Michelle Obama's Call to Action to Help Eradicate Obesity 3Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 2Health News:Nutritional Aid is Cost-effective Measure Against Health and Hunger Problems, World Vision Tells Congress 3Health News:Qualifacts is Behavioral Health SaaS Provider of Choice in Connecticut 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 2Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 3Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 4Health News:Orion Health Showcases Industry Leading EHR Software at WoHIT 5
... The Carriazo-Pendular microkeratome is based ... of the cornea during the cut., ... applanated evenly from the beginning of ... ensures that the intraocular pressure does ...
... Nicknamed the SRS, this new and innovative stent ... the office right at the chair with just ... medical grade silicone and is available in three ... separately). At each end of the stent is ...
... introduces the Halo Cordless Surgical Headlight, the ... headlight. Illuminated by innovative LED technology, and ... bright, white, cool light, guaranteeing phenomenal light ... hours of surgery. The Halo delivers a ...
... Using flying spot technology the Technolas 217z ... for personalized vision correction, allows surgeons in ... to -7.00 Diopters and astigmatism up to ... combines both a 2mm and 1mm truncated ...
Medicine Products: